Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
2 Biotech Stocks to Buy Hand Over Fist in October
10:15am, Wednesday, 09'th Oct 2024
These longtime leading biotech stocks still have plenty of upside ahead.
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
10:02am, Wednesday, 09'th Oct 2024
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
07:05pm, Monday, 07'th Oct 2024
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $448.16, signifying a -1.57% move from its prior day's close.
3 Top Stocks That Could Still Rocket Higher in 2024
05:17am, Friday, 04'th Oct 2024
Upcoming Food and Drug Administration decisions could push these stocks through the roof.
2 Superior Growth Stocks That Are Screaming Buys Right Now
04:45am, Friday, 04'th Oct 2024
These companies have plenty of growth runway left.
Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
07:06pm, Monday, 30'th Sep 2024
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $465.08, denoting a +0.48% change from the preceding trading day.
Wall Street Analysts See Vertex (VRTX) as a Buy: Should You Invest?
10:31am, Thursday, 26'th Sep 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first accepted medical presentations of the Phase 3 data on the investigational once daily vanzacaftor/t
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
10:05am, Wednesday, 25'th Sep 2024
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors
07:06pm, Monday, 23'rd Sep 2024
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $460, moving -1.06% from the previous trading session.
The Best Biotech Stock to Invest $1,000 in Right Now
05:50am, Sunday, 22'nd Sep 2024
Vertex Pharmaceuticals is unusually resilient for a biotech stock. The company has spectacular growth prospects with multiple promising late-stage programs.
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
10:15am, Saturday, 21'st Sep 2024
Diversification can help improve your portfolio's prospects in both bull and bear markets. Vertex is a top healthcare stock with an impressive track record and a superior outlook.
Biotech stock plays outside of GLP-1 weight-loss market
06:35pm, Thursday, 19'th Sep 2024
BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best biotech plays outside of the GLP-1 weight-loss space. The sky-high demand
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
05:49am, Wednesday, 18'th Sep 2024
Moderna hopes to win approvals for 10 programs by 2027. Vertex Pharmaceuticals could have multiple new blockbuster drugs on the market over the next few years.
Vertex Pharmaceuticals Incorporated (VRTX) Management presents at Cantor Global Healthcare Conference (Transcript)
11:52am, Tuesday, 17'th Sep 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Cantor Global Healthcare Conference September 17, 2024 9:10 AM ET Company Participants Susie Lisa - SVP, IR Manisha Pai - Executive Director, IR Conf
